• EPH137 Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Induced Weight Gain Among Children and Adolescents

    Jun 1, 2023, 00:00

  • MSR27 Predicting Return to Work after Traumatic Brain Injury: A Center-TBI Study

    Jun 1, 2023, 00:00

  • EE549 Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) Using the Standard of Care in Peru

    Jun 1, 2023, 00:00

  • HPR96 A Comparative Analysis of the Relationship between Orphan Drug Status and Reimbursement Status in Ireland, Sweden, France, and Canada in 2022

    Jun 1, 2023, 00:00

  • HSD78 Real-World Treatment Patterns Among Patients with Multiple Sclerosis in the US: An Electronic Health Records Analysis

    Jun 1, 2023, 00:00

  • EE198 When Patient Safety Is Also a Cost-Saving Strategy. A Retrospective Observational Study on Low Molecular Weight Heparins and Fondaparinux’s Appropriate Consumption in Tuscany

    Jun 1, 2023, 00:00

  • RWD151 A Machine Learning Approach to Predict the Risk of Fall for Elderly Patients Using Physiological Attributes from the Market Clarity Database

    Jun 1, 2023, 00:00

  • CO113 Incidence and Risk Factors of Newly Diagnosed Atrial Fibrillation in Colorectal Cancer Patients

    Jun 1, 2023, 00:00

  • CO10 Glucose Levels during the First 24 Hours and Mortality Among Critically Ill Adult Patients

    Jun 1, 2023, 00:00

  • EPH25 Adverse Drug Events Associated with Immune Checkpoint Inhibitors Atezolizumab, Nivolumab and Pembrolizumab: A Descriptive Retrospective Pharmacoepidemiologic Analysis Using FAERS Database 2014-2021

    Jun 1, 2023, 00:00

  • EE401 Characterizing the Impact on Work Productivity in Patients with Duchenne Muscular Dystrophy and Caregivers: An Economic Analysis

    Jun 1, 2023, 00:00

  • HTA44 Economic Modeling Insights for Ultra Orphan Drugs Based on Review of NICE Highly Specialized Technology (HST) Assessment Reports

    Jun 1, 2023, 00:00

  • EE60 The Socioeconomic Impact of Retinitis Pigmentosa (RP) in Japan

    Jun 1, 2023, 00:00

  • RWD82 To Study the Impact of Long COVID-19 in the US - A 9-Month Retrospective Study

    Jun 1, 2023, 00:00

  • PCR182 Study to Understand Women's Perception on the Recent Abortion Ban (BILL 302) in West Virginia

    Jun 1, 2023, 00:00

  • Potential Gains in Health-Adjusted Life Expectancy by Reducing Burden of Noncommunicable Diseases in 188 Countries: A Population-Based Study

    Jun 1, 2023, 00:00

  • HPR151 The Effect of the Inflation Reduction Act (IRA) on Benefit and Formulary Design, Including Drug Coverage and Selection, for Medicare D and Commercial Patients in the United States

    Jun 1, 2023, 00:00

  • Modeling Methods in Oncology

    Jun 1, 2023, 00:00

  • PCR176 Estimating Utility Values for Health States in Metachromatic Leukodystrophy (MLD)

    Jun 1, 2023, 00:00

  • MSR75 Machine Learning Models in Prediction of Head and Neck Squamous Cell Carcinoma Survivability

    Jun 1, 2023, 00:00

  • CO51 Understanding the Lived Experience of Patients By Mining Online Health Boards

    Jun 1, 2023, 00:00

  • PCR10 Both Dose Frequency and Modality Drive HIV Treatment Preferences Among People Living with HIV in the United States

    Jun 1, 2023, 00:00

  • EPH165 Geographic Variation of Antidementia Medication Use Among U.S. Nursing Home Residents with Dementia

    Jun 1, 2023, 00:00

  • PCR168 Differences in Patient-Reported Outcomes Among Breast Cancer Patients in Japan Based on Comorbidities Experienced: Results from a Cross-Sectional Survey

    Jun 1, 2023, 00:00

  • CO85 Association of Gabapentin Use with Functional Limitations Among Stroke Survivors: A Multi-Institutional Electronic Health Records Database Analysis

    Jun 1, 2023, 00:00

  • HTA54 Four Years of Implementing Health Technology Assessment in Ukraine: Achievements and Future Plans

    Jun 1, 2023, 00:00

  • HPR77 A Systematic Review of Equity Issues Experienced By Older Adults with Rare Diseases

    Jun 1, 2023, 00:00

  • EPH19 Awareness of Perinatal Depression Among Maternity Care Providers at Primary-Level in Yunnan Province, China

    Jun 1, 2023, 00:00

  • SA19 Real-World Targeted Literature Review of Intolerance with Tyrosine Kinase Inhibitor Treatment for Chronic Myeloid Leukemia

    Jun 1, 2023, 00:00

  • EE481 A Systematic Literature Review of Modeling Approaches in Economic Evaluations of Health Interventions for Attention Deficit Hyperactivity Disorder

    Jun 1, 2023, 00:00

  • EE418 Cost-Effectiveness Analysis of Halobetasol and Tazarotene (DUOBRIITM) Compared to Standard of Care for Adult Patients with Moderate-to-Severe Plaque Psoriasis in Québec

    Jun 1, 2023, 00:00

  • EE476 The Cost of Non-Cystic Fibrosis Bronchiectasis (NCFB) Patients with Commercial Insurance or Medicare Coverage in the United States

    Jun 1, 2023, 00:00

  • PCR92 Humanistic Burden of Illness in Demodex Blepharitis and Its Impact on Patients Lives Beyond the Presenting Symptoms

    Jun 1, 2023, 00:00

  • PCR144 Evaluation of the Association between Self-Perceptions of Aging and Care Deferrals Among US Adults Aged ≥50 Years during the COVID-19 Pandemic

    Jun 1, 2023, 00:00

  • CO156 Impact of Long-Acting Modality on the Management of the Parkinson's Disease

    Jun 1, 2023, 00:00

  • EE538 Cost-Utility Analysis of Revefenacin, Long-Acting Muscarinic Antagonist, Vs. Tiotropium, in the Treatment and Management of COPD

    Jun 1, 2023, 00:00

  • RWD116 Hospitalizations Among Patients with Both Colorectal Cancer and Type II Diabetes Mellitus Treated with Metformin Vs. Sulfonylureas: A Seer-Medicare Analysis

    Jun 1, 2023, 00:00

  • HSD58 Impact of the COVID-19 Pandemic on Cervical Cancer Screening Rates in Colombia: An Interrupted Time Series Analysis, Stratified By Region

    Jun 1, 2023, 00:00

  • EPH138 Osteogenesis Imperfecta: Epidemiology Characteristics and Disease Burden in Two Real-World Databases

    Jun 1, 2023, 00:00

  • HPR141 Comparisons of Medical Cost Trajectories between Non-Hispanic Black and Non-Hispanic White Patients with Newly Diagnosed Localized Prostate Cancer

    Jun 1, 2023, 00:00

  • CO34 Characterization of OCS Use in Patients Starting Biologics for Asthma in the United States

    Jun 1, 2023, 00:00

  • MSR70 Applying a Discrete Choice Experiment Methodology to Elicit Treatment Preferences for Patients with Tricuspid Regurgitation

    Jun 1, 2023, 00:00

  • SA42 Innovative Methods for Integrating Social Determinants of Health Data with Administrative Claims to Facilitate Health Equity Research

    Jun 1, 2023, 00:00

  • HPR122 Current Healthcare Policy and Environmental Status of Digital Health Medical Devices in South Korea

    Jun 1, 2023, 00:00

  • EE470 Cost-Effectiveness Assessment of Vacuum Therapy (SPONGE DEVICE) for Treatment of Anastomotic Fistula from Colorectal Surgery

    Jun 1, 2023, 00:00

  • Patient Experience Data in Regulatory Decision Making and Value Assessment

    Jun 1, 2023, 00:00

  • HTA32 Incorporating Equity into Health Technology Assessment: Key Learning from Informant Interviews

    Jun 1, 2023, 00:00

  • RWD57 Real-World Treatment Patterns of Elderly Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck in the US

    Jun 1, 2023, 00:00

  • CO162 A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients with Metastatic Renal Cell Carcinoma in Latin America

    Jun 1, 2023, 00:00

  • EE358 Estimated Costs of Malaria Treatment in the United States Among Privately Insured Patients and Medicaid Enrollees, 2015‒2019

    Jun 1, 2023, 00:00

  • EE454 Cost-Effectiveness of Screening for Atrial Fibrillation Utilizing the Unafied-7 Algorithm Versus Usual Care in Individuals Aged 65 from a US Payer Perspective

    Jun 1, 2023, 00:00

  • HPR56 Mapping the Provincial Management of New Medical Service Items in China

    Jun 1, 2023, 00:00

  • HSD96 Medication Utilization Patterns Among T2DM Patients Initiating Treatment with Oral Semaglutide

    Jun 1, 2023, 00:00

  • EPH32 The Epidemiology of Fragile X Syndrome in the United Kingdom

    Jun 1, 2023, 00:00

  • HPR154 Evaluation of the Updated French Autorisation D’Accès Précoce (AAP) Early Access Authorization Pathway

    Jun 1, 2023, 00:00

  • EE493 Equity in Healthcare Utilization and Reimbursement for Patients with Multiple Sclerosis in China: A Benefit Incidence Analysis Using Nationwide Patient-Reported Outcome Data

    Jun 1, 2023, 00:00

  • EE263 First-Year Costs of Care Associated with Non-Small Cell Lung Cancer (NSCLC) Among Medicare Beneficiaries

    Jun 1, 2023, 00:00

  • SA22 The Complexity Of Finding Fit-For-Purpose Real-World Data on Oncology Patients with Rare NTRK Gene Fusions and a Novel Solution

    Jun 1, 2023, 00:00

  • EE87 Insights and Lessons from Systematic Literature Review of Budget Impact Model Methodologies for United States Payers

    Jun 1, 2023, 00:00

  • EE250 Evaluation of Inpatient Healthcare Resource Utilization and Costs Pre- and Post- Nusinersen for the Treatment of Spinal Muscular Atrophy (SMA) Using US Claims

    Jun 1, 2023, 00:00

  • RWD100 Evaluation of an Electronic Medical Records-Based Spinal Muscular Atrophy Registry for Outcomes Research Readiness: Results from a Comprehensive Gaps Assessment

    Jun 1, 2023, 00:00

  • Methodological Statistical Research

    Jun 1, 2023, 00:00

  • PCR15 Long-Acting Injectable Antipsychotic Adherence Among Texas Medicaid Enrollees with Schizophrenia

    Jun 1, 2023, 00:00

  • HPR65 Client Satisfaction of the Rwanda Community Based Health Insurance (CBHI) Services and Benefits

    Jun 1, 2023, 00:00

  • PCR33 An Updated Analysis of Hemophilia Patient Utility Study of Treatment Administration Impact: A Discrete Choice Experiment (DCE) Using Time Trade-Off (TTO) Methodology

    Jun 1, 2023, 00:00

  • HPR42 Transportation Barriers to Cancer Care: Perceptions Among U.S. Community Oncologists

    Jun 1, 2023, 00:00

  • RWD17 Real-World Treatment Patterns and Overall Survival Among Follicular Lymphoma Patients: A SEER-Medicare Analysis

    Jun 1, 2023, 00:00

  • HPR148 A Disproportionality Analysis of the Serious Adverse Drug Events Associated with Gene Therapy Products Using the FDA Adverse Event Reporting System (FAERS)

    Jun 1, 2023, 00:00

  • HSD74 Health Plan Retention Improvements Associated with Companion Care in Elderly Populations

    Jun 1, 2023, 00:00

  • PCR181 The Burden of Familial Partial Lipodystrophy (FPL) in Brazilian Patients - A Qualitative Study on Physical Symptoms, Comorbidities, and Emotional Well-Being

    Jun 1, 2023, 00:00

  • MT2 HBA1C Reduction with Digital Health Devices in Type 2 Diabetes (T2DM): A Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2023, 00:00

  • CO90 Correlation between Length of Surgery and Opioid Overprescribing at Hospital Discharge

    Jun 1, 2023, 00:00

  • PROs and Patient Experiences in Oncology and Rare Diseases

    Jun 1, 2023, 00:00

  • EE316 Cost-Effectiveness of Pretomanid-Based Regimen for Treatment of Highly Drug-Resistant Tuberculosis in a High-Income Country

    Jun 1, 2023, 00:00

  • MSR93 A Systematic Review of Current Evidence and Gaps on the Impact of Oral Antipsychotic Treatments in Schizophrenia

    Jun 1, 2023, 00:00

  • CO100 The Effects of Obesity and Metabolic Syndrome on Kidney Transplant Outcomes in Young Patients: A Retrospective Study

    Jun 1, 2023, 00:00

  • PCR36 Vision-Related Quality of Life and Mental Health Outcomes of Children and Young People with Visual Impairment and Their Carers

    Jun 1, 2023, 00:00

  • PCR17 Work Productivity Assessment in Clinical Trials and Subsequent Economic Modeling in Multiple Sclerosis (MS) in Two Health Technology Assessment (HTA) Archetypes

    Jun 1, 2023, 00:00

  • EE47 Cost-Effectiveness of Abiraterone, Enzalutamide, and Apalutamide in Metastatic Castration-Sensitive Prostate Cancer (MCSPC): A Partitioned-Survival Model

    Jun 1, 2023, 00:00

  • EPH196 Updated Evidence of Hyperkalemia Occurren A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2023, 00:00

  • EPH234 Cancer-Related Disease Trauma: A Public Health Crisis

    Jun 1, 2023, 00:00

  • HPR99 Tobacco Smoking Prevalence Among Saudi Adults: Baseline for Evaluating the Implementation of Standardised Packaging for Tobacco Products

    Jun 1, 2023, 00:00

  • EE192 The Relationship between Systematic Lupus Erythematosus Disease Activity Index (SLEDAI) and Healthcare Resource Utilization and Costs in Lupus Patients

    Jun 1, 2023, 00:00

  • EE404 Healthcare Resource Utilization Among Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in Italy

    Jun 1, 2023, 00:00

  • EPH180 Examinination of Social Determinants of Health in Women's Health Cancer Screening

    Jun 1, 2023, 00:00

  • SA14 Assessing Risk of Bias in Systematic Literature Reviews: Which Tools Are Most Commonly Used?

    Jun 1, 2023, 00:00

  • EE79 Biomarker Testing in Rheumatoid Arthritis Leads to Lower Total Cost of Care

    Jun 1, 2023, 00:00

  • P54 Budget Impact Analysis (BIA) of the Use of Nonacog Beta Pegol in Patients with Haemophilia B in the Colombian Health System

    Jun 1, 2023, 00:00

  • EE372 Descriptive Analysis of Botulinum Toxin Use for Migraine and Member Costs in an Employed Population

    Jun 1, 2023, 00:00

  • PCR39 Preferences and Willingness to Pay of Medication for Patients with Renal Cell Carcinoma in China: A Discrete-Choice Experiment

    Jun 1, 2023, 00:00

  • EE104 Economic Evaluation of Multi-Sectoral Public Health Programmes: A Scoping Review

    Jun 1, 2023, 00:00

  • RWD101 Treatment of Pain Due to Endometriosis in a Large US Medical Claims Dataset

    Jun 1, 2023, 00:00

  • CO7 Clinical Effectiveness of Pacemaker in High-Risk Patients with Cardiovascular Diseases: A Systematic Review and Metanalysis

    Jun 1, 2023, 00:00

  • HSD67 Real-World Initiation of Recombinant Zoster Vaccine in U.S. Adults 51 Years or Older: A Commercial Claims Analysis

    Jun 1, 2023, 00:00

  • EE151 Cost-Minimization of Lorlatinib Versus Alectinib for First Line Treatment for Treatment of Alk-Positive Non–Small-Cell Lung Cancer from the Brazilian Private Healthcare System Perspective

    Jun 1, 2023, 00:00

  • CO16 Persistent Opioid Use after Hospital Admissions for Trauma in New Zealand

    Jun 1, 2023, 00:00

  • EPH143 Assessing the Association between Pain Severity and Poor Perceived Mental Health Among United States Adults Using the Meps 2019 Data

    Jun 1, 2023, 00:00

  • CO185 Assessing Clinical Outcomes in Patients with Transcatheter Aortic Valve Implantation (TAVI) in the Tuscany Region, Italy

    Jun 1, 2023, 00:00

  • MT41 Medical Technology Guidan A Review to Identify the Evidence Gaps and Data Needs

    Jun 1, 2023, 00:00

  • MT25 Assessing the Impact of a Patient Portal Application for Cancer Patients on Missed Appointments

    Jun 1, 2023, 00:00

  • CO164 Ribociclib Versus CDK4/6 Inhibitors and Endocrine Therapies (ET) for First Line (1L), Metastatic or Advanced HR+ HER2- Pre- and Post-Menopausal Breast Cancer in Asia: A Systematic Review and Network Meta-Analysis

    Jun 1, 2023, 00:00

  • EE222 Healthcare Costs Associated with Initial Combination Therapy Versus Monotherapy for Patients with Hypertension

    Jun 1, 2023, 00:00

  • Economic Evaluation

    Jun 1, 2023, 00:00

  • CO155 Modelling the Long-Term Effectiveness of Inebilizumab in the Current Treatment Landscape of NMOSD

    Jun 1, 2023, 00:00

  • EPH88 Machine Assisted Rapid Scoping Review: Current Therapeutic Trends for Tinnitus Cure and Control

    Jun 1, 2023, 00:00

  • A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021) [Editor's Choice]

    Jun 1, 2023, 00:00

  • PCR40 Waiting for a Good Kidney: Do Patients Think It’s Worth It?

    Jun 1, 2023, 00:00

  • EE262 Use of Single-Arm Trials in Cadth Reviews of Oncology Drugs

    Jun 1, 2023, 00:00

  • P35 Economic Benefit of Stroke Technology-Assisted Rehabilitation (STAR): A Scoping Review

    Jun 1, 2023, 00:00

  • MT22 Value Assessment of Prescription Digital Therapeutics

    Jun 1, 2023, 00:00

  • PCR103 Literature Review on the Use of Opt-out in Discrete Choice Experiments

    Jun 1, 2023, 00:00

  • PCR88 Perspectives of the Pedsql Generic Core Scales from Caregivers of Children with Spinal Muscular Atrophy (SMA)

    Jun 1, 2023, 00:00

  • EE55 Cost-Effectiveness of CDK 4/6 Inhibitors in the Treatment of HR+/HER2- Breast Cancer: A Systematic Review

    Jun 1, 2023, 00:00

  • EPH110 Structured Literature Review of Evidence on the Clinical, Humanistic, and Economic Burden of Primary Sclerosing Cholangitis

    Jun 1, 2023, 00:00

  • EPH248 Association of Various Characteristics with Self-Reported Exercise in Adults Age 50 Years or Older with Self-Reported Pain in the Past Four Weeks Who Had Also Used an Opioid

    Jun 1, 2023, 00:00

  • SA34 Real-World Treatment Outcomes Among Relapsed/Refractory Patients with Mantle Cell Lymphoma Treated with Ibrutinib or Acalabrutinib

    Jun 1, 2023, 00:00

  • RWD163 Population and Registry-Based Data Generation of Key Epidemiological Data for Cutaneous Melanoma in Colombia

    Jun 1, 2023, 00:00

  • EPH56 Prevalence and Predictors of Musculoskeletal Disorders Among Adults with Type II Diabetes

    Jun 1, 2023, 00:00

  • EE175 Cost-Effectiveness of Onasemnogene in Pre-Symptomatic Newborns with a Diagnosis of Spinal Muscular Atrophy and Two Copies of Survival Motor Neuron 2 Gene

    Jun 1, 2023, 00:00

  • RWD110 A Retrospective Analysis of Medicare Part D Compounded Products: Evaluating the Utilization of Compounded Products and Investigating the Limitations of Pharmacy Claims Data Reporting

    Jun 1, 2023, 00:00

  • EE32 Impact of Amyotrophic Lateral Sclerosis Disease Progression on Health Care Resource Use and Health-Related Quality of Life Using MiToS Staging and ALSFRS-R: Analysis of a Real-World Cross-Sectional Survey

    Jun 1, 2023, 00:00

  • PCR72 The Impact of Migraine on Canadians’ Productivity: A Real-World Pharmacy-Based Study

    Jun 1, 2023, 00:00

  • HSD46 A Systematic Survey on Lifestyle Assessment Tools

    Jun 1, 2023, 00:00

  • PCR186 Health State Utility and Quality of Life Measures for Neovascular Age-Related Macular Degeneration

    Jun 1, 2023, 00:00

  • OP18 Analogue Analysis - the Do's and Dont's

    Jun 1, 2023, 00:00

  • HPR83 Coming to America: How Ex-US Drug Companies May Best Prepare for the Complexities of a US Market Product Launch

    Jun 1, 2023, 00:00

  • MSR3 A Review of Predictive Modelling in Hypertension Based on Using Risk Factors to Predict Cardiovascular Consequences: A Targeted Literature Review (TLR)

    Jun 1, 2023, 00:00

  • RWD128 A Retrospective Claims Analysis Characterizing Health Care Resource Use Among Patients with Friedreich Ataxia in the United States

    Jun 1, 2023, 00:00

  • CO105 The Association of Sars-Cov-2 Infection and Tuberculosis Disease with Unfavorable Treatment Outcomes: A Systematic Review

    Jun 1, 2023, 00:00

  • PCR123 Patient-Centric Care (PCC) in Higher-Risk Myelodysplastic Syndromes (HR-MDS): A Global Systematic Literature Review (SLR) and Gap Analysis

    Jun 1, 2023, 00:00

  • MSR84 How Can Explainable Artificial Intelligence Accelerate the Systematic Literature Review Process?

    Jun 1, 2023, 00:00

  • HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting

    Jun 1, 2023, 00:00

  • HPR61 Horizontal Inequities in the Healthcare Expenditures on Ambulatory and Inpatient Care for Elderly in India: An Evidence from the National Sample Survey Data

    Jun 1, 2023, 00:00

  • MT53 Real World Patient Acceptance of Digital Therapeutics: A Review

    Jun 1, 2023, 00:00

  • PCR152 Development of the Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale (ABBA-CAS)

    Jun 1, 2023, 00:00

  • CO233 Driving Positive Patient Outcomes with Prior Authorization Analytics

    Jun 1, 2023, 00:00

  • CO146 Renal Outcomes of SGLT2 Inhibitors in Patients with Diabetes in the United States: Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • PCR162 Real-World Treatment Preferences Among People Living with ALS: A Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • EPH252 Contributions and Challenges of Pharmacists during a Public Health Crisis Such As COVID-19

    Jun 1, 2023, 00:00

  • RWD62 Real-World Characterization and Management of Alopecia Areata Patients in the U.S.

    Jun 1, 2023, 00:00

  • RWD170 Understanding Burden of Veno-Occlusive Disease (VOD): Comparison of Hospital Stays with Vod Principal Versus Secondary Diagnosis

    Jun 1, 2023, 00:00

  • RWD178 Real-World Treatment Patterns, Healthcare Resource Utilization (HRU) and Costs for Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL): Chimeric Antigen Receptor T-Cell (CAR T) and Monoclonal Antibodies (MAB) Therapies

    Jun 1, 2023, 00:00

  • HSD93 Associated Factors of Health Services Utilization for Patients with Chronic Diseases in Chengdu, China: An Application of Anderson’s Behavior Model

    Jun 1, 2023, 00:00

  • MT6 Global Systematic Review on the Incidence of Nd:Yag Laser Capsulotomy Post-Cataract Surgery in Eyes Implanted with the Clareon Intraocular Lens (IOL) Implanted Eyes

    Jun 1, 2023, 00:00

  • EE548 Healthcare Resource Use and Costs Associated with Oral Antibiotic Treatment Failure in Uncomplicated Urinary Tract Infection in the US

    Jun 1, 2023, 00:00

  • MSR18 Evaluating the Impact of Random Forest (RF) on Matching Adjusted Indirect Comparisons (MAICS) of Treatments between Trials: A Simulation Study

    Jun 1, 2023, 00:00

  • EE234 Cost Savings Associated with the Use of SITZMARKS® for the Diagnosis of Constipation in a Pediatric Population

    Jun 1, 2023, 00:00

  • SA31 Development of an Interactive Web-Based Report to Conduct and Visualize Evidence Synthesis for Facilitating Evidence-Based Decision Making in Health Care

    Jun 1, 2023, 00:00

  • CO88 Evaluating Six Month Mortality in CAR-T Patients in Medicare and Medicaid Patients

    Jun 1, 2023, 00:00

  • MSR26 External Validation of Parametric Survival Fitting of Mortality in Patients with Heart Failure

    Jun 1, 2023, 00:00

  • MT5 Cost-Minimization Analysis to Two Surgical Treatments of Benign Prostatic Hyperplasia in the Brazilian Private Health Sector

    Jun 1, 2023, 00:00

  • EPH105 Cardiovascular Disease Risk Among Hawaii's Alzheimer's Patients and Racial/Ethnic Disparities

    Jun 1, 2023, 00:00

  • EPH239 Treatment Pattern and Drug-Drug Interactions in Patients with Metastatic Castration Resistant Prostate Cancer

    Jun 1, 2023, 00:00

  • EE465 Value Estimation of the Diabetes Prevention Program: How Well Does Clinical Trial-Based Cost-Effectiveness Apply to the Real World?

    Jun 1, 2023, 00:00

  • CO135 Clinical and Economic Outcomes Associated with Transitions of Tobacco Use Among a Cohort of Adult Male Smokers Using U.S. Real-World Data

    Jun 1, 2023, 00:00

  • MSR31 Applying Multi-Level Network Meta-Regression (ML-NMR) to a Case Study in Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

    Jun 1, 2023, 00:00

  • P55 Budget Impact Analysis of COVID-19 Vaccines on U.S. Medicare and Commercial Health Plans after Depletion of the Federally-Purchased Supply

    Jun 1, 2023, 00:00

  • CO214 Model Predictions for Lifetime Health Benefits of Mobocertinib and Current Treatment Options in Post-Platinum Patients with Locally Advanced or Metastatic NSCLC Harboring Egfr Exon 20 Insertion Mutation in China

    Jun 1, 2023, 00:00

  • EPH57 Trends in Utilization, Spending, and Prices of Anti-Obesity Medications in Medicaid Programs: 22 Years Empirical Data Analysis, 1999 - 2021

    Jun 1, 2023, 00:00

  • SA65 Real-World Evidence Examining the Risk of Neurodegenerative and Cerebrovascular Diseases after Helicobacter Pylori Infection

    Jun 1, 2023, 00:00

  • HSD92 Relationship between Patient Experience of Primary Care and Their Utilization of Hospital Care: A Cross-Sectional Study in China

    Jun 1, 2023, 00:00

  • CO47 Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients with Heart Failure with Preserved Ejection Fraction: A Real-World Study

    Jun 1, 2023, 00:00

  • RWD93 Characteristics Associated with Self-Perceived Mental Health Among United States Adults with Skin Cancer

    Jun 1, 2023, 00:00

  • PCR171 Longitudinal Patterns of Adherence for Oral Endocrine Therapy Among US Women with Breast Cancer: A Group-Based Trajectory Modeling Study

    Jun 1, 2023, 00:00

  • RWD144 The Short Run and Long Run Behavioral Effects of COVID-19 Vaccination Enforcement

    Jun 1, 2023, 00:00

  • MSR39 Applying Machine Learning Techniques to Identify Undiagnosed Patients with Nonalcoholic Steatohepatitis (NASH)

    Jun 1, 2023, 00:00

  • HPR9 Do Children Experience Inequality of Opportunity in Childhood Malnutrition in Pakistan: Evidence from Pakistan Demographic and Health Survey

    Jun 1, 2023, 00:00

  • CO145 Comparison of Clinical Outcomes and Healthcare Utilization with Newer Diabetes Medications in Patients with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • EE213 Long COVID-19 Associated with 5-Fold Increase in Total Medical Costs and Greater Use of Inpatient and Outpatient Services Compared to Non-Long COVID-19: An Analysis of Real-World Data

    Jun 1, 2023, 00:00

  • HSD71 Situational Diagnosis of the Health Rehabilitation Network - A Strategy to Improve Post-Stroke Care in the Brazilian Public Health System

    Jun 1, 2023, 00:00

  • SA44 Digital Enrollment and Communication Acceptance for Decentralized Clinical Trial Participation

    Jun 1, 2023, 00:00

  • EPH224 Exploring the Association between Diseases of Despair and Industry and Occupational Setting Among US Workers: A Cross-Sectional Study Using the Medical Expenditure Panel Survey, 2016-2020

    Jun 1, 2023, 00:00

  • HTA101 Artificial Intelligence Bias in Systematic Literature Reviews (SLRS) for Health Technology Assessment (HTA)

    Jun 1, 2023, 00:00

  • PCR204 Real-World Evidence Collection in an Online Patient Community to Identify Lifestyle Challenges Considered Most Important to Patients with Chronic Pancreatitis

    Jun 1, 2023, 00:00

  • HPR35 Hospitalizations Associated with Type 1 Diabetes Reported By the Mexican Public Sector, 2018-2020

    Jun 1, 2023, 00:00

  • RWD94 Feasibility Study for Patient Journey Mapping for Ovarian Cancer Using Electronic Health Record Data

    Jun 1, 2023, 00:00

  • CO89 Effects of Ketogenic Diet on Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Clinical Trials

    Jun 1, 2023, 00:00

  • EE225 The High Cost of Death after Acute Myocardial Infarctions: Results from a National US Hospital Database

    Jun 1, 2023, 00:00

  • EPH54 Cancer Associations with Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

    Jun 1, 2023, 00:00

  • MSR38 Developing a Population-Level Disease Burden Model for Nash in the US: Methodological Challenges and Considerations

    Jun 1, 2023, 00:00

  • EE11 Cost-Effectiveness Analysis of Increasing Access to Colorectal Cancer Diagnosis in Countries with Limited Colonoscopy Capacities: An Example from Thailand

    Jun 1, 2023, 00:00

  • EE236 Healthcare Resource Utilization and Costs Associated with Acute COVID in Adult Patients Managed in the Community or Hospital Setting in England: A Population-Based Study

    Jun 1, 2023, 00:00

  • EE157 Budget Impact of a Blood-Based Integrated Classifier Test to Reclassify Risk of Pulmonary Nodules in a US Commercial Payer Setting

    Jun 1, 2023, 00:00

  • EPH193 Association between Self-Reported Pain Severity and Characteristics of US Adults Age ≥50 Years Who Used Opioids

    Jun 1, 2023, 00:00

  • PCR146 In-Trial Interview Sample Size: A Review of the Published Literature

    Jun 1, 2023, 00:00

  • MSR59 Prediction of Cardiovascular Disease in Psoriasis Patients Using Machine Learning Models Trained on Nordic Real-World Data

    Jun 1, 2023, 00:00

  • SA38 Approaches to Comparing Treatments from Meta-Analyses of Single-Arm Studies from a Systematic Literature Review: Case Example of Non-Surgical Technologies for Treatment of Lung Cancer

    Jun 1, 2023, 00:00

  • RWD63 Using a Novel Socioeconomic and Health Indicator Visualization Tool to Improve Minority Health

    Jun 1, 2023, 00:00

  • PCR8 Understanding and Assessing the Patient Experience of Symptoms for Polycystic Liver Disease (PLD): Development of a New Disease-Specific Symptom Patient-Reported Outcome Measure (PROM)

    Jun 1, 2023, 00:00

  • RWD92 Prevalence and Factors Associated with the Use of Direct Oral Anticoagulants Andlow Molecular Weight Heparins (LMWH) in Cancer Patients

    Jun 1, 2023, 00:00

  • EE514 A Cost-Effectiveness Analysis of Mosunetuzumab for Treatment of Third- or Higher-Line Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States (US)

    Jun 1, 2023, 00:00

  • EE208 Cost-Benefits of Parenteral Nutrition Read-to-Use Bags Versus Production in the Pharmacy in Brazilian Health System

    Jun 1, 2023, 00:00

  • SA4 Prognostic Factors and Effect Modifiers in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Failed at Least 2 Prior Lines of Therapy: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • HPR16 Incorporating Added Therapeutic Benefit and Domestic Reference Pricing into Medicare Payment for Expensive Part B Drugs

    Jun 1, 2023, 00:00

  • CO17 Machine Learning Analysis of Patient Engagement and One-Year Health Care Resource Utilization and Costs in Patients with Opioid Use Disorder Treated with a Prescription Digital Therapeutic

    Jun 1, 2023, 00:00

  • EE48 A Distributional Cost-Effectiveness Analysis of Cervical Cancer Screening Strategies in England

    Jun 1, 2023, 00:00

  • MT45 Cost-Effectiveness Analysis of Left Atrial Appendage Closure (LAAC) Device Vesus Warfarin and New Oral Anticoagulants (NOACS) in Patients with Atrial Fibrillation (AF) - Large Brazilian Healthcare Payer Perspective

    Jun 1, 2023, 00:00

  • EE380 Cost-Effectiveness Analysis of Erlotinib Plus Bevacizumab As First-Line Therapy for Advanced EGFR Mutation-Positive Non-Squamous Non-Small Cell Lung Cancer in Japan

    Jun 1, 2023, 00:00

  • MSR9 Exploratory Investigation of Factors Influencing Late Diagnosis in Merkel Cell Carcinoma in the United States

    Jun 1, 2023, 00:00

  • P28 Recalibration of Risk Prediction Equations for Cardiovascular Diseases in the Taiwanese Population with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • PCR153 Factors Associated with Glucose-Lowering Drug Adherence Among U.S. Adults with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • OP21 The Pharmaceutical Industry's Carbon Footprint and Current Mitigation Strategies: A Literature Review

    Jun 1, 2023, 00:00

  • CO218 Characteristics and Healthcare Utilization of Patients with Myasthenia Gravis Who Developed Exacerbation

    Jun 1, 2023, 00:00

  • EE172 National Inpatient Hospitalization Trends for Adult Patients with Cystic Fibrosis in the United States: A Retrospective Analysis

    Jun 1, 2023, 00:00

  • EE224 How Expensive Is a Stroke in the Caribbean Region of Colombia?

    Jun 1, 2023, 00:00

  • SA61 Systematic Review of Japanese Literature – A Study to Assess the Benefit of Including Japanese-Language Searches and Japanese-Specific Databases

    Jun 1, 2023, 00:00

  • EE417 Budget Impact Model of Neuromuscular Electrical Stimulation for the Treatment of Obstructive Sleep Apnea: An Exploratory Analysis

    Jun 1, 2023, 00:00

  • EE373 The Economic Impact of Adrenomyeloneuropathy (AMN) on Direct Medical Costs in Commercially Insured US Adults: A Retrospective Study

    Jun 1, 2023, 00:00

  • EE204 All-Cause Healthcare Costs By Race Among Medicaid-Insured Males with Duchenne Muscular Dystrophy Using U.S. Real-World Data

    Jun 1, 2023, 00:00

  • EE391 A Systematic Literature Review (SLR) of Economic Burden of Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Metastatic Breast Cancer (MBC) with at Least One Prior Therapy

    Jun 1, 2023, 00:00

  • PCR68 Association of Clinical Response Criteria and Disease Activity Levels with Physical Function and HRQoL in Patients with Axial Spondyloarthritis: 52-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies

    Jun 1, 2023, 00:00

  • MSR85 Making Health Economic Models More Efficient in Dealing with Contemporary Complexities

    Jun 1, 2023, 00:00

  • CO191 Clinical Effectiveness and Cost-Analysis of New Oral Antidiabetics in a Cohort of Type 2 Diabetic Patients from a Cardiovascular Risk Program in Colombia

    Jun 1, 2023, 00:00

  • CO221 Efficacy and Safety of Personalized Topography-Guided-Lasik Laser Refractive Correction: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • EE478 Cost-Effectiveness Analysis of Procalcitonin Compared to C-Reactive Protein (CRP) in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) in the Intensive Care Unit (ICU) in Medellín – Colombia

    Jun 1, 2023, 00:00

  • RWD158 Development of a Derived Induction Failure and Relapse (DIFR) Variable for Acute Myeloid Leukemia (AML) Using Real-World (RW) Data from an Electronic Health Record (EHR)-Derived Database

    Jun 1, 2023, 00:00

  • HTA42 Summary of Recent Health Technology Assessments for New Cancer Pharmacological Technologies in the Brazilian Private Healthcare System

    Jun 1, 2023, 00:00

  • EPH145 Renal Toxicity Boxed Warnings of Drugs Marketed in the US

    Jun 1, 2023, 00:00

  • PCR239 Patient-Driven Development of Meaningful Change Estimates in Chronic Pain

    Jun 1, 2023, 00:00

  • HTA89 The Inflation Reduction Act: What Makes a Price a Maximum Fair Price? – Lessons from Germany

    Jun 1, 2023, 00:00

  • PCR234 Impact of Draining Tunnels on Patient- and Physician-Reported Burden in Patients with Hidradenitis Suppurativa (HS)

    Jun 1, 2023, 00:00

  • RWD161 Real World Utilization of Androgen Deprivation Therapy Among Urology Practices: Characterizing Initiation and Transition to Relugolix for Patients with Prostate Cancer (THE REAL ADT TRANSITIONS STUDY)

    Jun 1, 2023, 00:00

  • HPR93 The Socio-Economic Capabilities of the Rwanda Community Based Health Insurance (CBHI) Beneficiaries

    Jun 1, 2023, 00:00

  • RWD25 Usage and Costs Profile of Long-Term Contraception Users at a Health Plan Operator in the Brazil

    Jun 1, 2023, 00:00

  • Challenges and Solutions for the Benefit Assessment of Tumor-Agnostic Therapies in Germany [Editor's Choice]

    Jun 1, 2023, 00:00

  • CO32 Heterotopic Ossification in Palovarotene-Treated and Untreated Individuals with Fibrodysplasia Ossificans Progressiva: Matched and Weighted Analyses

    Jun 1, 2023, 00:00

  • RWD67 The Use of Oxidized Zirconium Result in Beneficial Mortality and Readmission Outcomes, Evidence from a Real-World Evidence Study

    Jun 1, 2023, 00:00

  • EPH132 Effectiveness of Prostate Cancer Screening in Reducing Adult Mortality: A Quasi-Systematic Review

    Jun 1, 2023, 00:00

  • EPH216 The Use of Pharmacological Treatment Management Vs. the Use of Diet Quality to Evaluate the Health Outcomes in Managing Type 2 Diabetes

    Jun 1, 2023, 00:00

  • EE386 Economic Evaluation of Healthcare Resource Utilization and Costs for Patients with Newly Diagnosed Light-Chain Amyloidosis

    Jun 1, 2023, 00:00

  • RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and after First-Line mCRPC Therapy Initiation

    Jun 1, 2023, 00:00

  • MSR103 Comparative Study of Alternatives Non-Linear Dose-Response Regression Models

    Jun 1, 2023, 00:00

  • Copyright/Subscription

    Jun 1, 2023, 00:00

  • RWD23 Barriers to Persisting on Prophylactic Treatment for C1-Esterase Inhibitor Deficient Hereditary Angioedema; Observations from Community Immunology

    Jun 1, 2023, 00:00

  • EPH260 Patient, Clinical, and Hospital Characteristics Associated with Use of Z Codes and Social Determinants of Health in a Large, U.S. Hospital-Based, All-Payer Database

    Jun 1, 2023, 00:00

  • EPH92 A Retrospective Cohort Study of Veteran′s Affairs Data: Epidemiology, Treatments, Clinical Outcomes, and Burden of Focal Segmental Glomerulosclerosis

    Jun 1, 2023, 00:00

  • HPR130 The Impact of Stay-at-Home Orders on Binge Drinking Patterns in the US

    Jun 1, 2023, 00:00

  • PCR139 Estimating the Humanistic Burden of Nash for the US Population

    Jun 1, 2023, 00:00

  • MT8 A Cost-Utility Analysis of Artificial Urinary Sphincter Versus BSC in Severe Male Postprostatectomy Incontinence - Brazilian Public Health System Perspective

    Jun 1, 2023, 00:00

  • PCR225 Predictors of Health-Related Quality of Life across Rare Diseases: An Online Survey

    Jun 1, 2023, 00:00

  • CO23 Real-World Treatment Patterns and Survival with First-Line (1L) Pembrolizumab + Platinum + Taxane Therapy for Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the United States

    Jun 1, 2023, 00:00

  • EPH187 Inequities in Healthcare Expenditures for HIV Care in India: An Evidence from the Nationwide Cross-Sectional Data

    Jun 1, 2023, 00:00

  • EE127 Healthcare Resource Utilization Among Influenza Patients Treated with Baloxavir Marboxil Compared with Oseltamivir with Medicaid Insurance Coverage

    Jun 1, 2023, 00:00

  • RWD86 Real-World Dosing and Adherence in Patients with Multiple Sclerosis Treated with Nabiximols in Germany

    Jun 1, 2023, 00:00

  • PCR7 Association of Children's Type 1 Diabetes with Parents' Capability Well-Being Assessed By the ICECAP-A Measure

    Jun 1, 2023, 00:00

  • PCR175 Health-Related Quality of Life in Health States Corresponding to Different Stages of Perianal Fistula Associated with Crohn’S Disease: A Quantitative Evaluation of Patients and Non-Patients in Japan

    Jun 1, 2023, 00:00

  • OP9 Teaching Learning Strategies for Evidence Based Medicine Among Healthcare Professionals: A Systematic Review

    Jun 1, 2023, 00:00

  • EE233 Economic and Procedural Burden of Cannabinoid Hyperemesis Syndrome in the U.S. Emergency Department Setting: Unmet Need for a Diagnostic

    Jun 1, 2023, 00:00

  • MT10 Clinical, Operational, and Economic Impacts of Automated Medication Dispensing Cabinets in Perioperative and Ambulatory Surgical Center Settings: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • EE90 Cost-Effectiveness Analysis of Tumor Treating Fields in the Treatment of Newly Diagnosed Glioblastoma Based on Real-World Data

    Jun 1, 2023, 00:00

  • EE507 Integrated Budget Impact Analysis of Introducing Selpercatinib As a Tumor-Agnostic Treatment Option for Patients with RET-Altered Solid Tumors in the United States

    Jun 1, 2023, 00:00

  • CO75 Survival Difference in Pediatric Patients with Drug-Resistant Epilepsy: A Comparison of Three Treatment Groups

    Jun 1, 2023, 00:00

  • HTA16 Eliciting Preferences for Health Technology Assessment Criteria Using Analytic Hierarchy Process and Discrete Choice Experiment in Kenya

    Jun 1, 2023, 00:00

  • SA24 Patient-Driven RWD Outside of the Clinic: Demystifying the Capture of Home Reported Outcomes in Rare Diseases

    Jun 1, 2023, 00:00

  • MT43 Postoperative Hospital Costs after Anatomic and Reverse Total Shoulder Arthroplasty: A Retrospective, United States Hospital Billing Database Analysis

    Jun 1, 2023, 00:00

  • EE415 Burden of the Disease in Mexico of Respiratory Syncytial Virus Infection in Pediatric Patients Under 2 Years of Age with Risk Factors

    Jun 1, 2023, 00:00

  • SA15 Clinical Outcomes of Pharmacological Therapies for Heart Failure in Black Vs. White Populations: A Meta-Analysis of Randomized Controlled Trials of Heart Failure Treatment

    Jun 1, 2023, 00:00

  • EE158 Healthcare Resource Utilization and Costs Among Medicare Beneficiaries Initiating Venetoclax Vs. Btkis for Relapsed/Refractory Chronic Lymphocytic Leukemia: A Real-World Study

    Jun 1, 2023, 00:00

  • EE427 Analyzing the Impact of the Inflation Reduction Act of 2022 on Biosimilars in the United States: A Simulation with Adalimumab

    Jun 1, 2023, 00:00

  • PCR5 The Impact of Substantial Improvements in HBA1C and Weight Loss on the Medication Preferences of People with Type 2 Diabetes

    Jun 1, 2023, 00:00

  • EE426 A Comparison of the Cost-Saving Impact of Biosimilar Switching Policies across Canadian Provinces: A Case-Study for a Ranibizumab Biosimilar

    Jun 1, 2023, 00:00

  • MSR72 Sexually Transmitted Diseases Outbreak Prediction and Transmission Dynamics Understanding Using Agent-Based Modeling: Take the Global Spread of Male-Dominated and Msm-Dominated Mpox Outbreak As an Example

    Jun 1, 2023, 00:00

  • HSD30 Real-World Rearranged during Transfection [RET]-Alteration Testing, Treatment and Referral Patterns of Patients with Medullary and Papillary Thyroid Cancer [MTC, PTC] in Taiwan

    Jun 1, 2023, 00:00

  • RWD30 Adverse Event Reporting of Marketed Biosimilar and Biological Monoclonal Antibody Cancer Treatments in the United States

    Jun 1, 2023, 00:00

  • RWD184 Performance of the National Library of Medicine Rxmix, FDA National Drug Code Directory, and Redbook to Identify Prescription Records

    Jun 1, 2023, 00:00

  • HPR22 Real-World Evidence Usage in Regulatory Approvals from USFDA and EMA

    Jun 1, 2023, 00:00

  • EE291 Ethical Implications of Quality-Adjusted Life Year Assessments for Patients with Disabilities: A Duchenne Muscular Dystrophy Case Study

    Jun 1, 2023, 00:00

  • SA2 A Systematic Literature Review and Meta-Analysis of Work Productivity in Patients with Axial Spondyloarthritis Treated with Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs

    Jun 1, 2023, 00:00

  • HTA65 Societal and Governmental Perspective of Orphan Drugs - Is There an Impact on Value?

    Jun 1, 2023, 00:00

  • CO8 Design and Rationale of a Global Prospective Observational Study of Real-World Management of Patients with Atrial Fibrillation at High Risk of Stroke- Gardenia

    Jun 1, 2023, 00:00

  • P47 A Discrete Choice Experiment to Assess Patient-Informed Preferences for Major Depressive Disorder Treatment By Depression Severity

    Jun 1, 2023, 00:00

  • MSR33 Re-Training of the Artificial Intelligence (AI) Tool LIVESTARTTM with Additional Datasets: Updated Accuracy in the Title and Abstract Review Stage of Systematic Literature Reviews (SLR)

    Jun 1, 2023, 00:00

  • EPH141 Increased Risk of Anemia in Asthma Patients

    Jun 1, 2023, 00:00

  • HTA56 The Post-Brexit UK Access Landscape: Does Project Orbis Significantly Accelerate Patient Access for Oncology Drugs in the UK Versus Europe?

    Jun 1, 2023, 00:00

  • HTA50 HTA Bodies Acceptance of Indirect Treatment Comparisons for Gene Therapies in US, England and Wales, France and Germany

    Jun 1, 2023, 00:00

  • EE187 Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in the Treatment of Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Healthcare System Perspective: A Budget Impact Analysis

    Jun 1, 2023, 00:00

  • RWD21 Immunoglobulin a Nephropathy Patient Reported Health Utility and Quality of Life: Evidence from Real-World Data

    Jun 1, 2023, 00:00

  • EE456 Cost-Effectiveness Analysis of Non-Invasive Targeted Temperature Management Therapy Vs. Conventional Cooling Methods for Patients with Return of Spontaneous Circulation from Out-of-Hospital Cardiac Arrest in China

    Jun 1, 2023, 00:00

  • HPR14 Real-World Evidence (RWE) to Support Regulatory Submissions: Landscape Assessment Review

    Jun 1, 2023, 00:00

  • EPH198 The Sustained Impact of COVID-19 on Opioid Dispensing in California

    Jun 1, 2023, 00:00

  • RWD179 Comparison of Influenza Vaccination Coverage Estimated from Administrative Claims and Electronic Health Records with Population-Based Survey Estimates, U.S., 2017-2018 Influenza Season

    Jun 1, 2023, 00:00

  • EE339 Cost Benefits of Midazolam Ready-to-Use Solution Versus IV Drugs in Local Anesthesia

    Jun 1, 2023, 00:00

  • EPH73 Analyzing Mental Health Outcomes Among Pediatric Patients with Auditory Processing Disorder Caused By Head Trauma Using Real-World Data

    Jun 1, 2023, 00:00

  • EE322 Cost-Effectiveness Analysis of Intraoperative Neuromonitoring Versus Visual Identification of Recurrent Laryngeal Nerve in Total Thyroidectomy

    Jun 1, 2023, 00:00

  • EE305 Cost Burden of Geographic Atrophy and Visual Impairment/Blindness in US Elderly Patients

    Jun 1, 2023, 00:00

  • EE169 Real-World Analysis of Prevalence, Patient Characteristics, and Healthcare Resource Utilization and Costs (HRUC) Among Children with Food Protein-Induced Entercolitis Syndrome (FPIES) in the United States (US)

    Jun 1, 2023, 00:00

  • HSD60 Determining Costs, Cost Predictors, and Resource Requirements in Assisted Reproductive Technology Care Pathways: A Value-Based Fertility Care Costing Tool Using Time-Driven Activity-Based Costing

    Jun 1, 2023, 00:00

  • EE299 Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial

    Jun 1, 2023, 00:00

  • EPH128 Risk of Dementia Associated with Hormone-Modulating Breast Cancer Therapies Use in Older Women: A Nested Case-Control Study

    Jun 1, 2023, 00:00

  • EE509 Real-World Outpatient Cost of Care Among Patients with Melanoma Treated in the US Community

    Jun 1, 2023, 00:00

  • EE51 A Cost-Consequence Analysis of Adopting Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma in Saudi Arabia: a Multi-Center Comparison

    Jun 1, 2023, 00:00

  • P22 Severity Score Extraction from Unstructured Clinical Notes Using a Disease-Agnostic Natural Language Processing Question-Answering Pipeline

    Jun 1, 2023, 00:00

  • HPR126 How Do the Reimbursement Opportunities for Digital Health Applications Vary across the US, Europe and Japan?

    Jun 1, 2023, 00:00

  • EE342 Evaluation of the Cost-Effectiveness of Dapagliflozin Vs. Empagliflozin for Treating Heart Failure with Reduced Ejection Fraction in the United States

    Jun 1, 2023, 00:00

  • EE264 Immunotherapy for Advanced and Recurrent dMMR Endometrial Cancer: A Cost-Effectiveness Analysis

    Jun 1, 2023, 00:00

  • EPH186 What Do We Know about Utilization of Z Codes in the Pediatric Population? Exploring Variation in Z Code Use and Social Determinants of Health in a U.S. Hospital-Based, All-Payer Database

    Jun 1, 2023, 00:00

  • MSR41 Application of Artificial Intelligence As a Decision Support Tool for Abstract Screening: Implications for Time and Cost Savings

    Jun 1, 2023, 00:00

  • SA69 Spirometry Utilization Among Commercially Insured Individuals with Chronic Obstructive Pulmonary Disease (COPD)

    Jun 1, 2023, 00:00

  • EE366 Real-World Healthcare Resource Utilization and Cost By Relapse Frequency Among US Patients with Schizophrenia and Schizoaffective Disorder

    Jun 1, 2023, 00:00

  • P8 Bias in, Bias out? Implications of Using Real-World Data with Differentially Measured Outcomes to Generate Prediction Models When Race Is a Predictor

    Jun 1, 2023, 00:00

  • PCR124 Analyzing the Effect of Estrogen Deprivation Therapy Type on Sleep in Breast Cancer Survivors

    Jun 1, 2023, 00:00

  • EE286 A Systematic Review of Socioeconomic Burden in Hereditary Angioedema

    Jun 1, 2023, 00:00

  • EE408 Direct Cost Analysis Associated with the Management of Patients with Metachromatic Leukodystrophy (MLD) across Nine European Countries

    Jun 1, 2023, 00:00

  • CO81 Efficacy and Safety of Clascoterone Cream 1% in Patients with Acne vulgaris across Subgroups Defined By Demographic Characteristics

    Jun 1, 2023, 00:00

  • PCR134 Associations between HIV Stigma and Health-Related Quality of Life Among People Living with HIV in Zambia and South Africa: A Cross-Sectional Analysis of Data from the HPTN 071 (POPART) Study

    Jun 1, 2023, 00:00

  • EE64 Impact of Baseline Characteristics on Indirect Treatment Comparisons (ITCS) in Fabry Disease: A Systematic Literature Review (SLR)

    Jun 1, 2023, 00:00

  • CO190 Clinical Outcomes of Semaglutide 2.4 Mg in Patients with Obesity or Overweight in a Real-World Setting: A 6-Month Retrospective Study in the United States

    Jun 1, 2023, 00:00

  • CO144 Enoxaparin Sodium Biosimilar in the Prophylactic Treatment of Veinous Thromboembolism and Thromboembolic Disease: Prophyvar Study

    Jun 1, 2023, 00:00

  • HPR133 Introduction of an Integrated Review and Assessment System for Artificial Intelligence and Digital Innovative Medical Devices in Korea

    Jun 1, 2023, 00:00

  • MT17 Assessment of the Productivity Features and Analysis of the Quality Parameters from the Control Units Processed Using a Semi-Automated, Buffy Coat Method, in a Colombian Blood Bank Center

    Jun 1, 2023, 00:00

  • HPR76 Inequalities of the Infant Mortality and Poverty in Colombia: Analysis 1993 Vs 2019

    Jun 1, 2023, 00:00

  • EE406 Development of Scenarios By Health State to Measure the Quality of Life of Spinal Muscular Atrophy in the General Population

    Jun 1, 2023, 00:00

  • PCR20 Improvements in Symptoms, Impact of Treatment, and Satisfaction with Treatment Among Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Treated with Subcutaneous Epcoritamab

    Jun 1, 2023, 00:00

  • CO195 Incidence and Persistence of Post-COVID-19 Conditions in the Year Following Initial Diagnosis

    Jun 1, 2023, 00:00

  • EE512 Potential Long-Term Benefits of Extended Adjuvant Neratinib in Patients with High-Risk Hormone Receptor Positive (HR+) HER2+ Early-Stage Breast Cancer (ESBC) Following Use of T-DM1 or Pertuzumab: A Population Effectiveness Model

    Jun 1, 2023, 00:00

  • RWD173 Treatment Patterns, Healthcare Resource Utilization (HCRU), and Associated Costs in Patients with Newly Diagnosed Metastatic Urothelial Carcinoma (MUC): A Real-World Analysis of German Claims Data

    Jun 1, 2023, 00:00

  • HPR66 Health Technology Reassessment in Taiwan - Current Status

    Jun 1, 2023, 00:00

  • CO67 A Network Meta-Analysis of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma

    Jun 1, 2023, 00:00

  • HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System

    Jun 1, 2023, 00:00

  • EPH11 Evaluating Community Resilience through Social Media during the First Infection Wave Peak after Reopening in Beijing, China

    Jun 1, 2023, 00:00

  • CO116 Real-World Treatment Patterns, Healthcare Resource Use and Hospital Provider Cost of Recently Approved Treatments for Adult Relapsed or Refractory Acute Lymphoblastic Leukemia in the US: Blinatumomab and/or Inotuzumab Ozogamicin

    Jun 1, 2023, 00:00

  • EE557 Artificial Intelligen Optimizing the Efficiency of Screening Protocols for Women with Dense Breasts

    Jun 1, 2023, 00:00

  • HTA105 Use of Real-World Evidence to Support Direct Oral Anti-Coagulant Reimbursement and Implementation in Atrial Fibrillation. a Comparison of Experiences in Three Markets

    Jun 1, 2023, 00:00

  • CO112 Efficacy and Safety of Venetoclax+Rituximab in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of Bayesian Network Meta-Analysis

    Jun 1, 2023, 00:00

  • HTA82 Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • HSD59 Medical Chart Audit Study to Demonstrate Shortcomings of Corticosteroids in Treatment of Duchenne Muscular Dystrophy

    Jun 1, 2023, 00:00

  • HTA80 Cost-Effectiveness of Ocrelizumab Compared with Dmt for the Treatment of Relapsing-Remitting Multiple Sclerosis in Czech Republic

    Jun 1, 2023, 00:00

  • HPR104 Racial and Ethnic Disparities in Receiving Medications for Opioid Use Disorder: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • EPH36 Inherited Retinal Disease and Subsequent Use of Homecare: Findings from the National Registries in Sweden 2001-2021

    Jun 1, 2023, 00:00

  • PCR113 Treatment Preferences Among Adults with Reduced Productivity Due to Depression

    Jun 1, 2023, 00:00

  • SA47 Characteristics of United States Counties Utilized for Heart Failure Clinical Trial Sites

    Jun 1, 2023, 00:00

  • HPR17 PDCI's Biopharmaceutical Ecosystem Index: Where Does Canada Rank on Its Attractiveness for New Medicine Launch?

    Jun 1, 2023, 00:00

  • RWD121 Developing a Risk Prediction Model for the Early Identification of Alzheimer’s Disease (AD) in Elderly Patients

    Jun 1, 2023, 00:00

  • PCR34 Understanding the Experience of Patients with Primary Biliary Cholangitis and Pruritus

    Jun 1, 2023, 00:00

  • EE181 The Economic Burden of Preterm Labor (PTL): A Systematic Literature Review

    Jun 1, 2023, 00:00

  • RWD130 Differences in Healthcare Resource Utilization for the Management of Immunoglobulin a Nephropathy in Europe, the US, China and Japan

    Jun 1, 2023, 00:00

  • EE460 A Budget Impact Model to Evaluate the Economic Impact of Treating Walking Impairment in Chronic Stroke, A US Perspective

    Jun 1, 2023, 00:00

  • RWD111 Using a Centralized Platform to Integrate Retrospective and Prospective Data: Lessons Learned

    Jun 1, 2023, 00:00

  • HSD45 Potential Patient Hub Services Opportunities in the Ex-US Drug Market: Borrowing from US Experience

    Jun 1, 2023, 00:00

  • EE353 Cost-Effectiveness of Ravidasvir Plus Sofosbuvir Compared to the Standard of Care in Patients with Chronic Hepatitis C in the Thai Healthcare Setting

    Jun 1, 2023, 00:00

  • SA77 Real-World Data (RWD) and Innovative Decentralized Approaches – Putting the Patient First and Enhancing Patient Diversity

    Jun 1, 2023, 00:00

  • MSR20 NLP and Machine Learning to Automate Identification of Suspected Medication Errors from Real World Unstructured Narratives

    Jun 1, 2023, 00:00

  • EPH112 Economic Impact of Rapid Treatment Initiation of HIV with Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from a Canadian Healthcare Perspective

    Jun 1, 2023, 00:00

  • HPR137 Interventions to Address Healthcare Disparities Among Cancer Patients and Survivors in the United States: A Scoping Review

    Jun 1, 2023, 00:00

  • EE488 A Systematic Review on Economic Evaluations of Disease Modifying Interventions for Alzheimer’s Disease

    Jun 1, 2023, 00:00

  • HTA23 Cost-Effectiveness of Antiretroviral Therapy Adherence Interventions in People Living with HIV/AIDS: A Systematic Review of Decision Analytical Models

    Jun 1, 2023, 00:00

  • MT28 Association of Mode of Ventilation and Chest Radiograph in a Large US Cohort of Preterm Infants

    Jun 1, 2023, 00:00

  • PCR229 Impact of Fibrodysplasia Ossificans Progressiva on Living Adaptations and Employment: Burden of Illness Survey Results from the United States and Canada

    Jun 1, 2023, 00:00

  • HTA31 Cost-Utility Analysis of Pneumococcal Vaccines for Older Adults Available in Costa Rica

    Jun 1, 2023, 00:00

  • EE567 Economic Impacts of Short-Term Projections of the Judicialization of Medicines on the Expenditure and Budget for Pharmaceutical Assistance in Brazil

    Jun 1, 2023, 00:00

  • EPH21 Risk of Incident Cardiovascular Events with Disease-Modifying Antirheumatic Drugs Combinations Among Adult Patients with Rheumatoid Arthritis: A Nested Case-Control Study

    Jun 1, 2023, 00:00

  • EE75 The Economic Value and Learning Curves Associated with Laser Vision Correction

    Jun 1, 2023, 00:00

  • CO199 Development of a Novel Transdiagnostic Predictor of Psychiatric Hospitalization Using Early Trajectories of the Clinical Global Impression Scale

    Jun 1, 2023, 00:00

  • EE101 Use of Patient-Reported Outcomes As Key Drivers in Cost-Effectiveness Models: A Review of UK National Institute for Health and Care Excellence Health Technology Assessments

    Jun 1, 2023, 00:00

  • MSR23 Improving the Interpretability of Ordinal Endpoints in NMAs

    Jun 1, 2023, 00:00

  • EE423 Impact of Inclusion of Finerenone in the Burden of Disease of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Peru

    Jun 1, 2023, 00:00

  • RWD115 Assessing the Association of Various Characteristics with Perceived Level of Confidence Managing Diabetes Among United States Adults with Diabetes

    Jun 1, 2023, 00:00

  • OP8 Assessment of the PharmD Pharmacoeconomics Educational Environment in the United States

    Jun 1, 2023, 00:00

  • PCR49 The First Validated Innovation in Scale Design Since the Migration to Screens: Results of an Equivalence Study, Testing a New Graphical Version of the Widely Used Verbal Rating Scale

    Jun 1, 2023, 00:00

  • MSR34 Is the Usage of Immature Survival Data Surviving the HTA Decision?

    Jun 1, 2023, 00:00

  • EPH131 Estimation of the Population of Patients Eligible for Pirtobrutinib after Covalent Bruton Tyrosine Kinase Inhibitor (CBTKI) Discontinuation in the United States

    Jun 1, 2023, 00:00

  • PCR104 How Do Chinese Draft Guidelines (2021) on Patient Focused Drug Development Compare with Those of EMA and FDA?

    Jun 1, 2023, 00:00

  • P23 Machine Learning Approach for Analysis of Prodromal Phase for Early Risk Prediction in Multiple Sclerosis

    Jun 1, 2023, 00:00

  • EPH218 Cardiac Manifestations Including Heart Failure and Myocardial Infarction Post COVID-19 Recovery: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • RWD91 Assessing the Quality of Real-World Data and Real-World Evidence in Oncology Research: A Cohesive Framework for Researchers

    Jun 1, 2023, 00:00

  • PCR150 Effects of Smoking on the Prevalence of Self-Reported Antihypertensive Medication Use Among Community-Dwelling Stroke Survivors

    Jun 1, 2023, 00:00

  • EPH118 Retrospective Analysis of Acute Complications in Burn Injury Patients with Vitiligo

    Jun 1, 2023, 00:00

  • PCR116 Off Episode Quality of Life Impact Scale (OFFELIA) in People with Parkinson’s Disease: New Evidence of Construct Validity

    Jun 1, 2023, 00:00

  • RWD185 The Return on Investment of Real World Evidence

    Jun 1, 2023, 00:00

  • EPH194 Exploring the Association of Pain Severity and Perceived Health Status Among United States Adults Using 2019 Nationally Representative Data

    Jun 1, 2023, 00:00

  • EPH129 Comorbidity Patterns Among Older Women with Breast Cancer: A 10-Year Cohort Study Using an Unsupervised Machine Learning Approach

    Jun 1, 2023, 00:00

  • HPR79 Political Economy of NGO Contracting for TB Services through Govt Led Public Procurement System in Bangladesh

    Jun 1, 2023, 00:00

  • EE6 Healthcare Costs Associated with Micro- and Macro-Vascular Complications Among Populations with Metabolic Syndrome: A Nationwide Analysis

    Jun 1, 2023, 00:00

  • CO168 Defining Clinically Meaningful Thresholds (CMT) for Forced Vital Capacity (FVC) and Six-Minute Walk Test (6MWT) in Patients with Late-Onset Pompe Disease (LOPD)

    Jun 1, 2023, 00:00

  • PCR212 Correlation between Myasthenia Gravis Disease Severity and Impairment of Daily Living Activities of Real-World Patients in the United States and Five European Countries

    Jun 1, 2023, 00:00

  • HTA35 Implications of EU HTA on Future Relevance of Real World Evidence in National Assessments

    Jun 1, 2023, 00:00

  • PCR6 The Association between Administration Method, Socio-Demographic Characteristics, and Patient-Reported Outcomes for Glucagon-like Peptide-1 Receptor Agonists Among Diabetes Patients in Japan: A Cross-Sectional Patient Survey

    Jun 1, 2023, 00:00

  • P10 The Public's COVID-19 Fatigue and Mental Health Towards COVID-19 Public Health and Social Measures (PHSMS) and Mental Health in China: A Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • RWD41 Worsening Heart Failure Events after GDMT: What Contemporary Utilization of GDMT Among Patients with HFrEF Looks like in a U.S. Database

    Jun 1, 2023, 00:00

  • HPR55 Market Access Trends of Pharmaceutical Products in US, EU4 and UK (2016-2021)

    Jun 1, 2023, 00:00

  • HTA91 Health Impact of a Potential HIV Vaccine Among Men Who Have Sex with Men in the United States

    Jun 1, 2023, 00:00

  • EE270 The Economic Burden of Metastatic Non-Small Cell Lung Cancer in US Patients without an EGFR or ALK Mutation

    Jun 1, 2023, 00:00

  • EE185 Budget Impact of Anti-Inflammatory Reliever Therapy with Budesonide-Formoterol Combination in the Treatment of Mild Asthma in Panama

    Jun 1, 2023, 00:00

  • MSR99 Machine Learning Models to Estimate Disease Activity Measures in Real-World Data Sources: Lessons Learned from Four Autoimmune Diseases

    Jun 1, 2023, 00:00

  • EE558 Key Methodological Considerations for Developing Cost-Offset Budget Impact Models for a Range of Medical Technologies and Cost Perspectives in Ophthalmology

    Jun 1, 2023, 00:00

  • PCR4 A Targeted Literature Review of Disutilites for Type 2 Diabetes Treatment-Related Attributes

    Jun 1, 2023, 00:00

  • PCR233 Concept Elicitation Study to Characterize the Patient-Reported Experience of Gonorrhea Infection and Mapping of Concepts to Patient-Reported Outcome Measures

    Jun 1, 2023, 00:00

  • PCR84 The Urgency of Generating Real World Evidence Data to Bridge an Existing Gap between Randomized Clinical Trials and Clinical Practice in Rare and Orphan Kidney Diseases: An Ongoing Research from Main Available Platforms

    Jun 1, 2023, 00:00

  • MT13 In-House Versus Send-out Next Generation Sequencing Testing for Metastatic Non-Small Cell Lung Cancer Patients. a Budget Impact Analysis

    Jun 1, 2023, 00:00

  • PCR87 Impact of Signs and Symptoms of Chronic Refractory Gout on Patient Health-Related Quality of Life

    Jun 1, 2023, 00:00

  • CO220 Real-World Effectiveness and Safety in a Phase 4 Study of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis

    Jun 1, 2023, 00:00

  • PCR98 A Literature Review Assessing the Most Common Attributes Used in Stated-Preference Studies Assessing Influenza Vaccination: Do We Know What Health Care Professionals Value?

    Jun 1, 2023, 00:00

  • HTA46 Universal Screening with Cervicometry for the Prevention of Preterm Birth in Colombia: A Cost-Effectiveness Study

    Jun 1, 2023, 00:00

  • EE320 Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapies for Blood Cancers: A Systematic Review

    Jun 1, 2023, 00:00

  • CO183 The Use of NNT Modelling to Improve the Clinical Relevance of Economic Analyses

    Jun 1, 2023, 00:00

  • RWD133 Clinical Trial Emulation of the Catt Using Data from the Iris® Registry (INTELLIGENT RESEARCH IN SIGHT) Using Exact Matching and Inverse Probability Weighting

    Jun 1, 2023, 00:00

  • EE69 Extended Cost-Effectiveness Analysis of Varenicline for Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease in Thailand

    Jun 1, 2023, 00:00

  • HTA103 EU-HTA in 2025: Industry’S Stake in the Scoping Process

    Jun 1, 2023, 00:00

  • EE377 Cost-Effectiveness Analysis of Annual Routine Cognitive Assessment in People Living with HIV (PLWH) Aged 50 in the US

    Jun 1, 2023, 00:00
  • «
  • 21
  • 22 (current)
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • »